EcoDrugPlus

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPLAG00000009818
Gene Symbol: LOC106938703
3 Cross references
227 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPLAG00000009909
Gene Symbol: LOC106938705
3 Cross references
232 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPLAG00000023501
Gene Symbol: LOC106940483
3 Cross references
231 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPLAG00000003131
Gene Symbol: LOC106944035
3 Cross references
231 Possible Orthologues:

Sodium/glucose Cotransporter 2-Like

Ensembl ID : ENSPLAG00000021351
Gene Symbol: LOC106942277
3 Cross references
197 Possible Orthologues:

Sodium/hydrogen Exchanger 3-Like

Ensembl ID : ENSPLAG00000017548
Gene Symbol: LOC106946894
3 Cross references
234 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSPLAG00000007135
Gene Symbol: LOC106959198
2 Cross references
181 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2-Like

Ensembl ID : ENSPLAG00000020095
Gene Symbol: LOC106960171
3 Cross references
205 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-1-Like

Ensembl ID : ENSPLAG00000010051
Gene Symbol: LOC106945744
2 Cross references
219 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSPLAG00000003932
Gene Symbol: LOC106941936
2 Cross references
184 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233-Like

Ensembl ID : ENSPLAG00000020645
Gene Symbol: LOC106935418
3 Cross references
220 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSPLAG00000003434
Gene Symbol: LOC106959891
3 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).